Article
DNA methylation profiling reveals a predominant immune component in breast cancers
12 Sept 2011
Abstract excerpt
Breast cancer is a molecularly, biologically and clinically heterogeneous group of disorders. Understanding this diversity is essential to improving diagnosis and optimizing treatment. Both genetic and acquired epigenetic abnormalities participate in cancer, but the involvement of the epigenome in breast cancer and its contribution to the complexity of the disease are still poorly understood. By means of DNA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
